Search results
Jun 12, 2023 · Detailed Dabigatran dosage information for adults and children. Includes dosages for Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis - Prophylaxis, Venous Thromboembolism and more; plus renal, liver and dialysis adjustments.
Medscape - VTE prevention/treatment dosing for Pradaxa (dabigatran), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...
Detailed dosage guidelines and administration information for Pradaxa (dabigatran etexilate mesylate). Includes dose adjustments, warnings and precautions.
Dosing and Administration of Pradaxa® (dabigatran etexilate) Dosing & Management. In this section: Information on starting your adult patients on PRADAXA Capsules, including a comprehensive dosing table. Instructions on converting adult patients to PRADAXA Capsules.
Dosage. Side effects. Interactions. FAQ. What is Pradaxa? Pradaxa (dabigatran) belongs to a class of anticoagulant medications called direct thrombin inhibitors. Dabigatran works by preventing blood clots from forming in the body.
For a heart problem called atrial fibrillation or a blood clot (DVT or pulmonary embolism), the usual dose is 150mg twice a day. For a hip or knee joint replacement the usual dose is 110mg twice a day. Your doctor may give you a lower dose if you're at increased risk of bleeding. This includes if you: are aged 75 years or older.
Feb 17, 2020 · Capsule, Oral: Pradaxa: 75 mg [contains fd&c yellow #6 (sunset yellow)] Pradaxa: 110 mg, 150 mg [contains fd&c blue #2 (indigotine)] Pradaxa: 150 mg [contains fd&c blue #2 (indigotine), fd&c yellow #6 (sunset yellow)] Pharmacology.
What Is Pradaxa? Pradaxa (dabigatran) is an anticoagulant that works by blocking the clotting protein thrombin. Pradaxa is used to prevent blood clots from forming because of a certain irregular heart rhythm ( atrial fibrillation ). Preventing these blood clots helps to reduce the risk of a stroke. What Are Side Effects of Pradaxa?
Generic Medicine Info. Indications and Dosage. Oral. Prophylaxis of venous thromboembolic events following knee replacement surgery. Adult: Initially, 110 mg given within 1-4 hours after surgery, followed by 220 mg once daily for 10 days.
75-mg & 110-mg cap: Primary prevention of venous thromboembolic (pVTEp) events in adult patients who have undergone elective total hip or knee replacement surgery. 110-mg & 150-mg cap: Reduce risk of stroke & systemic embolism in patients w/ non-valvular atrial fibrillation (SPAF).
